This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The artificial intelligence in the diagnostic market size has grown exponentially in recent years. It will grow from $4.29 billion in 2024 to $5.99 billion in 2025 at a compound annual growth rate (CAGR) of 39.5%. The growth in the historic period can be attributed to rising disease burden, data availability, cost reduction, regulatory support, increasing awareness.
The artificial intelligence in the diagnostic market size is expected to see exponential growth in the next few years. It will grow to $22.59 billion in 2029 at a compound annual growth rate (CAGR) of 39.4%. The growth in the forecast period can be attributed to personalized medicine trends, rapid increase in healthcare data, global health challenges, increased investments, enhanced integration with healthcare systems. Major trends in the forecast period include collaboration and investment, advancements in technology, data privacy and security concerns, rise of explainable ai (xai), expanding role of computer vision.
The anticipated growth of AI in the diagnostics market is attributed to the increasing prevalence of chronic diseases. Chronic diseases, characterized by their prolonged duration, present a persistent health challenge lasting for an individual's lifetime. The integration of AI-based diagnostic processes in managing chronic diseases offers advantages such as early detection, prediction, improved decision support systems, remote patient monitoring, cost reduction, and personalized treatment plans tailored to individual patients based on their genetic makeup and disease progression. As of September 2023, the World Health Organization reported 41 million annual fatalities, constituting 74% of global non-communicable disease (NCD) or chronic disease-related deaths. Notably, cardiovascular diseases accounted for 17.9 million deaths, cancer for 9.3 million deaths, chronic respiratory diseases for 4.1 million deaths, and diabetes for 2 million deaths. Therefore, the escalating prevalence of chronic diseases is a key driver behind the growth of AI in the diagnostics market.
Major companies in the AI in diagnostics market are actively engaged in developing cutting-edge technologies, including AI modules, to enhance their market competitiveness. An AI module, defined as a self-contained software component housing specific AI capabilities or functionalities, plays a pivotal role in this landscape. For example, in March 2023, Qritive, a Singapore-based provider of AI-powered solutions, introduced QAI Prostate, designed for prostate cancer diagnosis. This innovative solution efficiently identifies the most common form of prostate cancer, potentially enhancing diagnostic accuracy and reducing false positives. QAI Prostate assists pathologists in distinguishing cancerous from non-cancerous tissue areas, facilitating informed treatment decisions. Additionally, the tool streamlines case prioritization for faster diagnosis and reporting, contributing to improved efficiency and patient care.
In June 2024, Quest Diagnostics Inc., a US-based provider of diagnostic information services, acquired the assets of PathAI Diagnostics for an undisclosed amount. This acquisition enables Quest Diagnostics to enhance its capabilities in AI and digital pathology, particularly in cancer diagnosis, by integrating PathAI's innovative technologies with its existing diagnostic services. PathAI Inc. is a US-based company known for providing advanced AI and digital pathology solutions, specializing in improving diagnostic accuracy for biopharmaceutical companies and pathology laboratories. This move strengthens Quest Diagnostics' position in leveraging AI to deliver more precise and efficient healthcare solutions.
Major companies operating in the artificial intelligence in the diagnostic market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Paige.AI Inc., HeartFlow Inc., Aidoc Medical Ltd., AliveCor Inc., Butterfly Network Inc., Imagen Technologies, Digital Diagnostics Inc., Brainomix Ltd., NovaSignal Corp., Enlitic Inc., Nano-X Imaging LTD., EchoNous Inc., Zebra Medical Vision Ltd., Aidence B.V., Neural Analytics Inc., IDx Technologies Inc., icometrix N.V., Vuno Inc.
North America was the largest region in the artificial intelligence in diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in the diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the AI in diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The AI in diagnostics market consists of revenues earned by entities by providing services such as medical imaging analysis, disease prediction, and genomic sequencing analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in diagnostics market also includes sales of AI-powered imaging systems, AI-driven pathology tools, and point-of-care diagnostic devices Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
AI in diagnostics involves the application of artificial intelligence (AI) technologies in medical diagnosis, utilizing advanced algorithms, machine learning, and data analysis techniques to interpret medical data, images, and clinical information. The purpose of implementing AI in diagnostics is to enhance the accuracy, speed, and efficiency of medical diagnoses.
The primary components of AI in the diagnostic market include hardware, software, and services. Hardware pertains to the physical parts of a computer system or other electronic device. In AI in diagnostics, hardware plays a crucial role in improving processing power, enabling real-time analysis, ensuring scalability, facilitating integration with imaging devices, enhancing energy efficiency, ensuring security, promoting interoperability, customization, and reliability. These factors collectively contribute to more effective and efficient diagnostic processes in healthcare. Various technologies, including machine learning, natural language processing (NLP), context-aware computing, and computer vision, find application in various diagnostic types such as radiology, pathology, cardiology, oncology, neurology, chest and lung, among others.
The artificial intelligence in the diagnostic market research report is one of a series of new reports that provides artificial intelligence in the diagnostic market statistics, including the artificial intelligence in the diagnostic industry global market size, regional shares, competitors with artificial intelligence in the diagnostic market share, detailed artificial intelligence in the diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in the diagnostic industry. This artificial intelligence in the diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The artificial intelligence in the diagnostic market size has grown exponentially in recent years. It will grow from $4.29 billion in 2024 to $5.99 billion in 2025 at a compound annual growth rate (CAGR) of 39.5%. The growth in the historic period can be attributed to rising disease burden, data availability, cost reduction, regulatory support, increasing awareness.
The artificial intelligence in the diagnostic market size is expected to see exponential growth in the next few years. It will grow to $22.59 billion in 2029 at a compound annual growth rate (CAGR) of 39.4%. The growth in the forecast period can be attributed to personalized medicine trends, rapid increase in healthcare data, global health challenges, increased investments, enhanced integration with healthcare systems. Major trends in the forecast period include collaboration and investment, advancements in technology, data privacy and security concerns, rise of explainable ai (xai), expanding role of computer vision.
The anticipated growth of AI in the diagnostics market is attributed to the increasing prevalence of chronic diseases. Chronic diseases, characterized by their prolonged duration, present a persistent health challenge lasting for an individual's lifetime. The integration of AI-based diagnostic processes in managing chronic diseases offers advantages such as early detection, prediction, improved decision support systems, remote patient monitoring, cost reduction, and personalized treatment plans tailored to individual patients based on their genetic makeup and disease progression. As of September 2023, the World Health Organization reported 41 million annual fatalities, constituting 74% of global non-communicable disease (NCD) or chronic disease-related deaths. Notably, cardiovascular diseases accounted for 17.9 million deaths, cancer for 9.3 million deaths, chronic respiratory diseases for 4.1 million deaths, and diabetes for 2 million deaths. Therefore, the escalating prevalence of chronic diseases is a key driver behind the growth of AI in the diagnostics market.
Major companies in the AI in diagnostics market are actively engaged in developing cutting-edge technologies, including AI modules, to enhance their market competitiveness. An AI module, defined as a self-contained software component housing specific AI capabilities or functionalities, plays a pivotal role in this landscape. For example, in March 2023, Qritive, a Singapore-based provider of AI-powered solutions, introduced QAI Prostate, designed for prostate cancer diagnosis. This innovative solution efficiently identifies the most common form of prostate cancer, potentially enhancing diagnostic accuracy and reducing false positives. QAI Prostate assists pathologists in distinguishing cancerous from non-cancerous tissue areas, facilitating informed treatment decisions. Additionally, the tool streamlines case prioritization for faster diagnosis and reporting, contributing to improved efficiency and patient care.
In June 2024, Quest Diagnostics Inc., a US-based provider of diagnostic information services, acquired the assets of PathAI Diagnostics for an undisclosed amount. This acquisition enables Quest Diagnostics to enhance its capabilities in AI and digital pathology, particularly in cancer diagnosis, by integrating PathAI's innovative technologies with its existing diagnostic services. PathAI Inc. is a US-based company known for providing advanced AI and digital pathology solutions, specializing in improving diagnostic accuracy for biopharmaceutical companies and pathology laboratories. This move strengthens Quest Diagnostics' position in leveraging AI to deliver more precise and efficient healthcare solutions.
Major companies operating in the artificial intelligence in the diagnostic market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Paige.AI Inc., HeartFlow Inc., Aidoc Medical Ltd., AliveCor Inc., Butterfly Network Inc., Imagen Technologies, Digital Diagnostics Inc., Brainomix Ltd., NovaSignal Corp., Enlitic Inc., Nano-X Imaging LTD., EchoNous Inc., Zebra Medical Vision Ltd., Aidence B.V., Neural Analytics Inc., IDx Technologies Inc., icometrix N.V., Vuno Inc.
North America was the largest region in the artificial intelligence in diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in the diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the AI in diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The AI in diagnostics market consists of revenues earned by entities by providing services such as medical imaging analysis, disease prediction, and genomic sequencing analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in diagnostics market also includes sales of AI-powered imaging systems, AI-driven pathology tools, and point-of-care diagnostic devices Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
AI in diagnostics involves the application of artificial intelligence (AI) technologies in medical diagnosis, utilizing advanced algorithms, machine learning, and data analysis techniques to interpret medical data, images, and clinical information. The purpose of implementing AI in diagnostics is to enhance the accuracy, speed, and efficiency of medical diagnoses.
The primary components of AI in the diagnostic market include hardware, software, and services. Hardware pertains to the physical parts of a computer system or other electronic device. In AI in diagnostics, hardware plays a crucial role in improving processing power, enabling real-time analysis, ensuring scalability, facilitating integration with imaging devices, enhancing energy efficiency, ensuring security, promoting interoperability, customization, and reliability. These factors collectively contribute to more effective and efficient diagnostic processes in healthcare. Various technologies, including machine learning, natural language processing (NLP), context-aware computing, and computer vision, find application in various diagnostic types such as radiology, pathology, cardiology, oncology, neurology, chest and lung, among others.
The artificial intelligence in the diagnostic market research report is one of a series of new reports that provides artificial intelligence in the diagnostic market statistics, including the artificial intelligence in the diagnostic industry global market size, regional shares, competitors with artificial intelligence in the diagnostic market share, detailed artificial intelligence in the diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in the diagnostic industry. This artificial intelligence in the diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Artificial Intelligence in the Diagnostic Market Characteristics3. Artificial Intelligence in the Diagnostic Market Trends and Strategies4. Artificial Intelligence in the Diagnostic Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Covid and Recovery on the Market32. Global Artificial Intelligence in the Diagnostic Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Artificial Intelligence in the Diagnostic Market34. Recent Developments in the Artificial Intelligence in the Diagnostic Market
5. Global Artificial Intelligence in the Diagnostic Growth Analysis and Strategic Analysis Framework
6. Artificial Intelligence in the Diagnostic Market Segmentation
7. Artificial Intelligence in the Diagnostic Market Regional and Country Analysis
8. Asia-Pacific Artificial Intelligence in the Diagnostic Market
9. China Artificial Intelligence in the Diagnostic Market
10. India Artificial Intelligence in the Diagnostic Market
11. Japan Artificial Intelligence in the Diagnostic Market
12. Australia Artificial Intelligence in the Diagnostic Market
13. Indonesia Artificial Intelligence in the Diagnostic Market
14. South Korea Artificial Intelligence in the Diagnostic Market
15. Western Europe Artificial Intelligence in the Diagnostic Market
16. UK Artificial Intelligence in the Diagnostic Market
17. Germany Artificial Intelligence in the Diagnostic Market
18. France Artificial Intelligence in the Diagnostic Market
19. Italy Artificial Intelligence in the Diagnostic Market
20. Spain Artificial Intelligence in the Diagnostic Market
21. Eastern Europe Artificial Intelligence in the Diagnostic Market
22. Russia Artificial Intelligence in the Diagnostic Market
23. North America Artificial Intelligence in the Diagnostic Market
24. USA Artificial Intelligence in the Diagnostic Market
25. Canada Artificial Intelligence in the Diagnostic Market
26. South America Artificial Intelligence in the Diagnostic Market
27. Brazil Artificial Intelligence in the Diagnostic Market
28. Middle East Artificial Intelligence in the Diagnostic Market
29. Africa Artificial Intelligence in the Diagnostic Market
30. Artificial Intelligence in the Diagnostic Market Competitive Landscape and Company Profiles
31. Artificial Intelligence in the Diagnostic Market Other Major and Innovative Companies
35. Artificial Intelligence in the Diagnostic Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Artificial Intelligence In The Diagnostic Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on artificial intelligence in the diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial intelligence in the diagnostic? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in the diagnostic market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Component: Hardware; Software; Services2) By Technology: Machine Learning; NLP (Natural Language Processing); Context-Aware Computing; Computer Vision
3) By Diagnosis Type: Radiology; Pathology; Cardiology; Oncology; Neurology; Chest And Lung; Other Diagnosis Types
Subsegments:
1) By Hardware: Imaging Devices; Diagnostic Equipment; Wearable Devices2) By Software: Diagnostic Imaging Software; Data Analytics Software; Machine Learning Algorithms; Clinical Decision Support Systems
3) By Services: Consulting Services; Integration Services; Maintenance And Support Services; Training Services
Key Companies Mentioned: Google LLC; Microsoft Corporation; Intel Corporation; IBM Corporation; Siemens Healthineers
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Artificial Intelligence in Robotics market report include:- Google LLC
- Microsoft Corporation
- Intel Corporation
- IBM Corporation
- Siemens Healthineers
- Koninklijke Philips N.V.
- GE Healthcare Technologies Inc.
- Paige.AI Inc.
- HeartFlow Inc.
- Aidoc Medical Ltd.
- AliveCor Inc.
- Butterfly Network Inc.
- Imagen Technologies
- Digital Diagnostics Inc.
- Brainomix Ltd.
- NovaSignal Corp.
- Enlitic Inc.
- Nano-X Imaging LTD.
- EchoNous Inc.
- Zebra Medical Vision Ltd.
- Aidence B.V.
- Neural Analytics Inc.
- IDx Technologies Inc.
- icometrix N.V.
- Vuno Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 5.99 Billion |
| Forecasted Market Value ( USD | $ 22.59 Billion |
| Compound Annual Growth Rate | 39.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
